Safeguarding Lives Against Battlefield Threats

Geneva leads mission-driven research to mitigate chemical, biological, radiological, nuclear, and explosive (CBRNE) threats. By advancing diagnostics, treatments, and protective technologies, we safeguard service members in high-risk environments and strengthen national security. Our work addresses prevention, detection, mitigation, and response—improving survivorship, enhancing operational readiness, and building resilience against hazardous exposures and weapons of mass destruction.

Why CBRNE Research Matters

CBRNE research is critical to protecting service members facing unique and elevated risks:

• • • Increased Burn Injury Risk: Deployed service members are twice as likely as civilians to suffer burn injuries.

    • Airborne Hazards: Since 1990, more than 3.7 million U.S. service members have been exposed to burn pit emissions, oil well fire smoke, vehicle exhaust, and sand during deployments.

    • Readiness Impact: Addressing these hazards is essential to force health protection, operational performance, and long-term survivorship.

Geneva Advantage

With deep DoD expertise and agile contracting infrastructure, Geneva transforms innovation into mission-ready solutions that protect the force and advance national defense.

• • • Access to Military Assets: Collaborations with military treatment facilities, federal laboratories, and research partners advance cutting-edge CBRNE solutions.

    • Proven Performance: Decades of experience navigating military-focused research and funding mechanisms deliver measurable outcomes for the warfighter.

    • Comprehensive Expertise: Specialized capabilities in detection technologies, medical countermeasures, and environmental remediation address the full lifecycle of CBRNE threats.

By leveraging these strengths, Geneva accelerates the transition from discovery to deployment—delivering real-world applications that protect lives and strengthen security at home and abroad.